Wistar Wire: Cancer

Ben Leach
Dmitry Gabrilovich, M.D., Ph.D.
Dmitry Gabrilovich, M.D., Ph.D.
In addition, a paper from last month on genome organization was recognized for being one of the most relevant papers in biology by a panel of peers.
Cancer
Ben Leach
Chi Van Dang, M.D., Ph.D.
Chi Van Dang, M.D., Ph.D.
Some of the nation’s top oncology experts and National Cancer Institute leaders gathered in Washington, D.C., to present a plan to accelerate new advances in cancer diagnosis, prevention and treatment.
Cancer, Events, Funding
Ben Leach
Wistar scientists have published new studies on fundamental aspects of melanoma metastasis and therapy resistance, the application of a novel immunotherapeutic technology to prevent infection with antibiotic-resistant bacteria, and the discovery of new aspects of the three-dimensional organization of the genome. Also, the National Institutes of Health (NIH) selected a Wistar principal investigator for her innovative epigenetics research.
Ben Leach
New studies have demonstrated how tumor cells and immune cells adapt their metabolism to cope with the shortage of nutrients and oxygen in the tumor microenvironment and how these processes affect the sustained fight between cancer and the immune system. Three Wistar studies on this subject have been recently featured in top-tier journals. A principal investigator at Wistar was also recognized for his HIV research.
Awards, Cancer, HIV-AIDS